Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 15Unknown 3Active not recruiting 3Withdrawn 2Terminated 1Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 47Lymphoid 43Plasma cell 26Sarcoma 19Myeloid 19Breast 11Dermatologic 10CNS 10Genitourinary 9Gynecologic 7Classical hematology 6Other solid neoplasm 5Gastrointestinal 4Head & Neck 3Endocrine 3NET 2Thoracic 1Other 1

Conditions

Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

Carboplatin 158Pemetrexed 135Cisplatin 115pembrolizumab 98Docetaxel 94Paclitaxel 89Gemcitabine 63Erlotinib Hydrochloride 60Radiotherapy 55Nivolumab 55Bevacizumab 46Etoposide 42atezolizumab 33Radiosurgery 33durvalumab 27Cyclophosphamide 22Vinorelbine 21Ipilimumab 21Radiation 20Taxes 17130-nm albumin-bound paclitaxel 17Albumin-Bound Paclitaxel 16Gefitinib 14Irinotecan 13Drug Therapy 13osimertinib 12avelumab 12Magnetic Resonance Spectroscopy 12Dexamethasone 12Vorinostat 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Filgrastim × Thoracic × Clear all
NCT00113386 2013-06-28

Cisplatin and Docetaxel With or Without Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Newly Diagnosed Stage III Non-Small Cell Lung Cancer

Radiation Therapy Oncology Group

Phase 3 Terminated
19 enrolled 5 charts
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡